No evidence for capsule replacement following mass immunisation with meningococcal serogroup C conjugate vaccines in England and Wales
- 31 October 2006
- journal article
- other
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 6 (10), 616-617
- https://doi.org/10.1016/s1473-3099(06)70584-9
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Meningococcal polysaccharide–protein conjugate vaccinesThe Lancet Infectious Diseases, 2005
- First Report of Capsule Replacement among Electrophoretic Type 37 Neisseria meningitidis Strains in ItalyJournal of Clinical Microbiology, 2003
- Capsule Switching among C:2b:P1.2,5 Meningococcal Epidemic Strains after Mass Immunization Campaign, SpainEmerging Infectious Diseases, 2002
- W135 meningococcal disease in England and Wales associated with Hajj 2000 and 2001The Lancet, 2002
- Meningococcal conjugate vaccines: new opportunities and new challengesThe Lancet, 1999
- Meningitis caused by a serogroup W135 clone of the ET‐37 complex of Neisseria meningitidis in West AfricaTropical Medicine & International Health, 1998
- Serogroup B, Electrophoretic Type 15Neisseria meningitidisin CanadaThe Journal of Infectious Diseases, 1998
- Capsule switching of Neisseria meningitidisProceedings of the National Academy of Sciences, 1997
- Antigenic and Epidemiologic Properties of the ET-37 Complex of Neisseria meningitidisThe Journal of Infectious Diseases, 1993